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ABSTRACT 
Housekeeping genes frequently used in gene expression studies are highly 
regulated in human adipose tissue. To ensure a correct interpretation of results, it is 
critical to select appropriate reference genes. Subcutaneous and omental adipose 
tissue expression was analyzed from lean and obese subjects using  whole genome 
cDNA microarrays to identify stably expressed genes and  commercial Taqman Low 
Density Arrays (LDAs), with 16 common control genes. The best candidate gene 
from microarrays analysis was F-box and leucine-rich repeat protein-10 (FBXL10) 
(fold-change 10-3 p<0.01), an ubiquitous nucleolar protein evolutionarily conserved. 
Hypoxanthine-phosphoribosyl-transferase-1 (HPRT1) and Importin-8 (IPO8), were 
the best reference genes among the 16 genes in the LDAs with coefficients of 
variation (CV) of 4.51% and 4.55%, respectively. However, when the LDAs data 
were further analyzed by the geNORM and Normfinder softwares, IPO8, a nuclear 
protein mediating import of proteins, was the first and the third better reference 
gene, respectively. IPO8 and FBXL10 were further validated by Real-Time PCR in 
additional omental and subcutaneous fat samples and primary cultured  
preadipocytes. According to their CV, IPO8 resulted more suitable than FBXL10 in 
both adipose tissue depots and subcutaneous preadipocytes, while FBXL10 
performed better than IPO8 in omental cultured preadipocytes, . Both genes 
expression levels did not change throughout adipogenesis. 
Thus,  we provide clear evidence that IPO8 and FBXL10 are good candidates to use 
as reference genes in gene expression studies in human omental and 
subcutaneous adipose tissues as well as differentiated primary preadipocytes. 
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INTRODUCTION 
 
Endogenous or reference genes are those that are constitutively expressed in all 
tissues and have an essential role in the maintenance of the cellular function (1). In 
line with this role, it is generally assumed that their expression levels are similar in 
different conditions or cell types. However, it has been shown that genes usually 
considered as reference genes exhibit large variations in different tissues or 
experimental conditions (2-5).  
Regarding the adipose tissue, a highly regulated and complex organ, the 
bibliography describes as housekeeping genes some that are regulated under 
hormonal stimulation or during adipogenic differentiation. That is the case of 
glyceraldehyde-3-phosphate dehydrogenase (GAPDH), beta-actin (ACTB) or 18S 
ribosomal RNA (18S) (6-9). It seems fundamental to choose a good control gene in 
order to allow an adequate analysis of gene expression studies. When working with 
a single tissue or cell type, this is solved using a gene whose expression levels 
remain constant in those specific samples; however, in human adipose tissue, the 
expression of genes is different depending on their anatomical location 
(subcutaneous (SC) or omental (OM)). As OM adipose tissue differs considerably 
from the subcutaneous SC depot, physiological and gene expression differences 
have been reported between both localizations (10-12). 
The aim of this study was to find the most suitable reference gene for gene 
expression studies in human adipose tissues and primary cultures of preadipocytes, 
using microarrays and statistical methods. For this purpose we evaluated the 
variation in gene expression level in SC and OM adipose samples from lean and 
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obese subjects using Taqman® Endogenous Control Arrays Low Density Arrays 
(LDA), which contain 16 control genes normally used in the literature as 
endogenous genes, and to compare the results with stable genes obtained from 
microarrays. Though microarrays are commonly applied to find genes with 
differential expression across experimental conditions, the data may also be used to 
identify stably expressed genes (5). Different stability algorithms have been used 
with microarray data, in order to select candidate genes based on the fold 
expression changes (13, 14), variance of expression (15) or integrative correlations 
(16).The statistical methods used in our study were geNORM, Normfinder and 
analysis of coefficient of variance (%CV). 
In this study we show that IPO8 and FBLX10 are two previously unidentified genes, 
which are good control genes for expression studies involving human isolated 
differentiated preadipocytes and whole adipose tissue. 
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METHODS AND PROCEDURES 
 
Subjects 
 
Human adipose tissue was obtained from the OM and SC depots from 45 obese 
patients, 20 males and 25 females, undergoing bariatric surgery. Five of these 
patients were diabetic. OM and SC adipose tissue from 4 lean (3 males and 1 
female) subjects were also obtained by Nissen fundoplication. The samples were 
immediately frozen and stored at -80º C until processed. Surgeries were performed 
at the Hospital Universitario La Paz (Madrid), Hospital Clínico S. Carlos (Madrid) 
and Clínica Universitaria de Navarra (Pamplona). Patients were classified as obese 
or lean according to their body mass index (BMI), calculated as the ratio between 
the weight in kilograms and the square of the height in meters. Obese patients were 
40.4 ± 1.7 years old and showed a BMI of 49.7 ± 1.1 kg/m2 (mean ± SEM) whereas 
lean subjects were 47.5 ± 7.1 years old and presented a BMI of 23.8 ± 0.3 kg/m2. 
Basal glucose, triglycerides and total cholesterol concentrations in plasma were 114 
± 6 mg/dl, 139 ± 19 mg/dl and 182 ± 5 mg/dl in obese patients, respectively, while 
the respective concentrations of lean patients were 91 ± 1, 71 ± 12 and 197 ± 13 
mg/dl. Although glucose and triglycerides were significantly different between both 
groups (p<0.05), variables were within the normal range. All subjects gave informed 
consent. The protocols were approved by the Ethical Committees of the Hospitals 
and our institution, and are in agreement with the European laws on biomedical 
research and with the principles of the Declaration of Helsinki. 
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Primary cultures of human omental preadipocytes. 
Human adipose tissue was obtained from the abdominal OM and SC regions 
from 8 additional obese patients (7 women and 1 men) undergoing bariatric surgery. 
Patients with a mean age of 43.9 ± 4.1 yr, showed a BMI of 49.3 ± 2.2 kg/m2, with 
no other pathologies. The protocol followed the ethical considerations as above. 
 Preadipocytes were isolated and differentiated under defined adipogenic 
conditions (17). After a 10 days differentiation period, cells were treated for 48 h 
with 10% depleted serum in presence or absence of insulin (3 nM), and treated (or 
not) with 2 nM triiodothyronine, rosiglitazone (1 µM), dexamethasone (100 nM), 
hydrocortisone (100 nM) or norepinephrine (5 µM) during the last 24 h. Cells were 
harvested at day 12 of differentiation. Depleted serum was obtained as follows: first, 
hypothyroid serum was obtained by depleting heat-inactivated fetal bovine serum of 
thyroid hormones with the anion exchange resin AG1-X8 as described (18). 
Depleted serum was obtained by treatment of hypothyroid serum with charcoal 
overnight (20 mg charcoal/ ml serum). This treatment further depleted serum from 
the remaining thyroid hormones and other hormones such as insulin and 
glucocorticoids. After harvesting the cells, total RNA was extracted.  
In differentiation experiments, cells were just differentiated without any further 
treatment and harvested at 0, 6 and 12 days. 
 
RNA extraction 
Approximately 100 mg of each adipose sample was used to extract RNA with the 
RNeasy lipid tissue kit (QIAGEN, Madrid, Spain) following the protocol provided by 
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the manufacturer. RNA integrity and concentration were checked by the Bioanalyzer 
2100 (Agilent Technologies, Santa Clara, CA). 
 
Microarrays  
 
“Human Genome Survey Microarray V2.0” from Applied Biosystems (Foster 
City, CA) contains 60-mer oligonucleotides specific for 32,878 probes corresponding 
to 29,098 genes. The data set includes genes from both public databases (RefSeqs, 
GenBank and Mammalian Gene Collection) and the Celera® Genomics database 
(Rockville, MD). Ten arrays were utilized for OM adipose tissue and 14 for SC 
adipose tissue from men and women. Total RNA samples obtained from 12 obese 
and 4 lean subjects were amplified into digoxigenin labelled cRNA using Applied 
Biosystem Chemiluminiscent RT-ITV Labeling KIT (Foster City, CA) according to 
the manufacturer´s directions. The amplified and labelled cRNA was injected into 
each microarray hybridization chamber and hybridized at 55 ºC for 16 h. Detection 
at 458 nm was performed with the Chemiluminiscent Detection kit (Applied 
Biosystems, Foster City, CA) and image acquisition was carried out using the 1700 
Chemiluminiscent Microarray Analyzer.  
Arrays data were read, pre-processed and filtered according to the platform 
manufacturer´s recommendation with the Applied Biosystems software (Foster City, 
CA). For Applied Biosystems Expression Arrays, an excellent signal detection is set 
as signal to noise (S/N)> 3 and quality flag< 5000. Thus, probes having a S/N ratio 
below 3 and a Flag value above 5,000 in all samples were discarded. After filtering, 
14,564 genes in the OM depot and 19,183 genes in the SC depot from the original 
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29,098 genes were obtained. Before being compiled into an expression profile data 
matrix, all arrays were quantile-normalized to be comparable because this method 
ensures that the intensities have the same empirical distribution across arrays. 
Genes differentially expressed were selected by using the LIMMA package(19) from 
the Bioconductor project (http://www.bioconductor.org) (20) contained in the Spotfire 
Integromics software. The statistical analysis described above was performed by 
Integromics (Granada, Spain).  Among the rest of the genes not diferentially 
expressed, we selected as stable those genes which in both depots showed a fold 
change < 0.01.  
 
TaqMan® Low Density Endogenous Control  Panel microfluidic cards 
To validate the variation in gene expression levels of various commonly used 
endogenous controls, a TaqMan® Low Density Endogenous Control Panel was 
used (Applied Biosystems, Foster City, CA). This microfluidic card (or LDA) contains 
16 human Taqman® Gene Expression Assays (Table 1). Each LDA has a 3 well 
replicate for each assay, and eight ports for loading of cDNA and Taqman Universal 
Master Mix  (Applied Biosystems, Foster City, CA) in a final volume of 100 µl. The 
384-well micro fluid cards were run in the following PCR program: 50 °C for 2 min, 
94 °C for 10 min and 40 cycles of 97 °C for 30 s followed by 60 °C for 1 min. To 
measure RNA quantity (Ct), samples were monitored by the Applied Bioystem 
7900HT Fast Real-Time PCR System (Foster City, CA).  
OM and SC adipose tissues from 4 obese and 4 lean subjects were used. Fifty 
nanograms of each RNA were reversed-transcribed with the High Capacity RNA to 
cDNA kit (Applied Biosystems, Foster City, CA) following the manufacturer´s 
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instructions. Each sample was loaded in one of the eight ports of the microfluidic 
cards, analyzed in triplicates obtaining an average Ct and the coefficient of variation 
(CV). This CV equals the standard deviation divided by the mean Ct (expressed as 
percentage) and was used to compare the variation degree among the 16 control 
genes. In addition to CV analysis, geNORM Visual Basic (21) and Normfinder 
applications for Microsoft Excel (15) were used to confirm results. Each of these 
methods generates a measure of reference gene stability, which can be used to 
rank the reference genes in order of stability. Both softwares generate a stability 
value of which a lower value indicates increased stability in gene expression.  
Taqman RT-PCR 
A further analysis was performed with conventional Taqman RT-PCR, using pre-
designed Taqman Assays on demand (Applied Biosystems, Foster City, CA) for 
IPO8, 18S, FBXL10, leptin, interleukin 6 and adiponectin. For cDNA synthesis, 1 µg 
of total RNA was reverse transcribed in a 20 µl final volume using iScriptTM cDNA 
Synthesis Kit (BioRad, Hercules, CA) according to the manufacturer’s instructions. 
Real-time PCR reactions were performed on a 7300 Real Time PCR System 
(Applied Biosystems, Foster City, CA). 
 
Statistical Analysis 
 
Results are expressed as means ± standard error of the mean (SEM). Significance 
of differences between two groups is shown, and it was measured by Student`s t-
test. Statistical analysis of microarrays and LDAs have been explained in the 
corresponding sections. 
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RESULTS 
Microarray gene expression analysis  
A whole genome microarray assay analysis from a group of human adipose tissue 
(OM and SC adipose tissue from 4 lean and 12 obese subjects) (unpublished 
results) identified genes with a moderate abundance, which were consistently 
expressed in all the samples across the study. Among them, those with a fold-
change <0.01 in both, OM and SC depots were chosen. From 29,098 genes 
analyzed, 44% and 58% of the OM and SC genes, respectively, were expressed 
with a good signal quality. Among these, 42 genes were found in OM adipose tissue 
and 248 genes in SC fat tissue with a stable expression, exhibiting at least a p 
<0.01. After comparing stably expressed genes from both depots, only 2 genes 
were common to OM and SC localizations, FBXL10 and FTCD. FBXL10 is a 
nucleolar protein that belongs to the JHDM family (JmjC-domain-containing histone 
demethylase), while FCTD (Forminotransferase-cyclo deaminase) is a bifunctional 
enzyme, a metabolic intermediate between the catabolism of histidine and that of 
folate. Considering the features of both proteins, we proposed FBXL10 as the most 
adequate as a control gene to perform further analyses, because it is an ubiquitous 
protein that is conserved evolutively and regulates transcription of ribosomal genes 
(18S, 5S, 8 S and 28S), which are essential for the maintenance of cell functions.  
Taqman Low Density Arrays 
To look for possible endogenous controls for gene expression in human adipose 
tissue, we used predesigned Taqman low density arrays with a panel of 16 human 
genes that are commonly used as endogenous controls (cat#4367563, Applied 
Biosystems, Foster City, CA). The genes are shown in Table 1. 
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cDNA from 16 different samples of adipose tissue (4 OM from lean, 4 OM from 
obese, 4 SC from lean and 4 SC from obese individuals) were run down all channels 
of 2 identical microfluidic cards with 16 endogenous genes. The data obtained were 
virtually identical with a correlation coefficient of 0.989, which shows that variability 
of gene expression between microfluidic cards is negligible. 
Two samples from obese patients of each depot were run in triplicates in the 4 
channels of each microfluidic card with the 16 control genes and compared to 
another card, in which 2 samples from lean OM and SC tissue were loaded. Except 
for 18S with the highest expression, the other genes exhibited Cts ranging from 23 
to 32 cycles. Mean Ct values for FBXL10 (the most stable gene from microarrays) in 
OM and SC adipose tissue samples were 31.34 ± 0.32 and 31.96 ± 0.34 
respectively. 
The data showed a low coefficient of variation (CV%) between wells. Data are 
shown in Table 1. 
Taking OM and SC samples as a whole, the control genes with the most stable 
expression were HPRT1 and IPO8, whereas the genes with high variation in the 
expression levels were 18S, RPLP0, ACTB and GAPDH, which are widely used as 
reference genes. When analyzing individually OM and SC tissues, HPRT1 was not 
as suitable as IPO8 in OM tissue, thus we decided to perform a further evaluation of 
stability. For this purpose, we analyzed the results from the LDAs with two powerful 
previously published Microsoft Excel-based softwares: the geNORM and the 
NormFinder programs. Both are available freely on internet sites 
(http://medgen.ugent.be/genorm and http://www.mdl.dk) geNorm determines the 
most stable reference genes from a set of tested genes within a panel, and 
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calculates a gene expression normalization factor for each tissue sample based on 
the geometric mean of a user-defined number of reference genes (21). From 
geNORM results (Figure 1, upper panel), HPRT1 resulted to have the third highest 
M value whereas the two genes with the lowest M value were PPIA and IPO8, 
confirming that IPO8 is very suitable as a reference gene in adipose tissue. When 
NormFinder program was used with the 16 reference genes (Figure 1, lower panel), 
RPLP0 and GAPDH resulted the first and second genes in the ranking, while IPO8 
turned out to be the third more suitable gene. Considering the results from the 3 
analysis used (%CV, Genorm and Normfinder), IPO was the most suitable gene 
because its rankings were consistent with the 3 methods: 1st (Genorm), 2nd (%CV) 
and 3rd (NormFinder), despite some discrepancies with other genes. Although 
GAPDH with NormFinder resulted the second best gene, we think it is not suitable 
because its %CV was 7.06% (Rank 13) and in addition, as said in the introduction 
section, it is well described as a gene whose expression varies in different 
conditions in adipocytes. In a similar way, RPLP0 was ranked as 1st by NormFinder 
and 2nd by Genorm, however, it was ranked the last but one gene (Rank 15) by the 
%CV method. In addition, there are concerns about using ribosomal protein genes 
as reference. 
The following step was to check in 30 subjects using both adipose localizations, the 
stability of IPO8 (the most suitable gene from LDA) versus 18S (the most used in 
the literature), and versus FBXL10 (the most stable gene from our microarray data) 
by real time RT-PCR. When CVs were compared, the 18S showed a coefficient of 
variation of 17.1%, while the CV of FBXL10 and IPO8 were 3.61% and 3.04%, 
respectively.  
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In order to further evaluate the reference gene stability on a gene whose expression 
is well known to be elevated in obese patients, leptin was normalized to 18S, IPO8 
or FBXL10 (Figure 2, panels A and B). Figure 2 shows that only normalization with 
IPO8, but not with 18S or FBXL10, reflected the normal increase in leptin expression 
in both omental and subcutaneous depots. Other genes such as adiponectin and 
interleukin 6 were studied in the same samples. Adiponectin expression in omental 
samples showed a tendency to decrease with all reference genes, but only was 
significant with 18S, and almost with IPO8 (p=0.05) (Figure 2, panel C). In SC 
adipose tissue, adiponectin showed the opposite pattern with the 3 reference genes, 
but changes only were significant with IPO8 (Figure 2, panel D). Interleukin 6 
increased significantly in omental adipose tissue only when it was normalized with 
IPO8 (150-fold change) or FBXL10 (76-fold change) (Figure 2, panel E), while no 
changes were observed in SC samples with any of the reference genes (Figure 2, 
panel F). 
To further investigate the role of IPO8 and FBXL10 as reference genes, we decided 
to check it in primary cultures of human OM and SC adipocytes submitted to 
different treatments, in absence or presence of insulin, triodothyronine, 
norepinephrine, dexamethasone, hydrocortisone and rosiglitazone. The expression 
of both FBXL10 and IPO8 was not changed by the different treatments. Although 
both genes presented a good CV in these cultured adipocytes, FBXL10 exhibited a 
slightly better and lower CV than IPO8 (0.85% vs 0.95%) in the adipocytes from the 
omental depot, while IPO8 showed better CV than FBXL10 in those adipocytes from 
SC origin (2.15% vs 3.05%, respectively). 
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We further analyzed the IPO8 and FBXL10 expression at different days of 
differentiation (0, 6 and 12 days) of OM and SC cultured preadipocytes to study if 
these transcripts are modulated through adipogenesis. When data from 
differentiation experiments were taken as a whole, the %CV were 3.0% and 3.2% 
for FBXL10 and IPO8 respectively in OM adipocytes. GAPDH was also measured 
showing a higher CV of 6.3%. In SC differentiated preadipocytes FBXL10, IPO8 and 
GAPDH showed a CV of 2.51%, 2.54% and 6.73% respectively. The levels of 
expression of the three genes obtained from each differentiation day in adipocytes 
from both depots appear in Figure 3. As seen, no variations of Ct were observed for 
FBXL10 and IPO8, in contrast to GAPDH that showed significant changes along 
differentiation. Due to the exponential nature of this technique, each cycle (Ct) 
difference implicates a two-fold change in the real mRNA levels. The lack of 
variations of FBXL10 and IPO8 transcripts throughout differentiation reinforces their 
use as reference genes in this type of cultures of adipose cells, in contrast to 
GAPDH mRNA changes. 
Adipocyte differentiation was checked by visual inspection of the cells which 
accumulated lipids progressively and by measuring the mRNA levels of leptin and 
aP2, two well known markers for late adipogenesis. The relative fold-change of 
leptin mRNA increased from 1.0 ± 0.2 at day 0, to 1.8 ± 0.10 at day 6 and 11.9 ± 4.5 
at day 12 (p<0.05 vs day 0) in the OM adipocytes, and from 1 ± 0.5 (day 0) to 2.1 ± 
0.6 (day 6) and to 7.0 ± 0.4 (day 12, p<0.05 vs day 0) in adipocytes from SC origin. 
Changes at day 6 were not significant. The relative fold-change of aP2 was 1± 0.3, 
2158.0 ± 349.7, 392.4 ± 119.3 at 0, 6 and 12 days in OM adipocytes, respectively, 
and 1± 0.35, 4799.5 ± 750.7 and 3283.1 ± 532.4 at the same times in SC cells. All 
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changes in the aP2 transcript were significant (p<0.01) when compared to their 
respective day 0. 
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DISCUSSION 
A determinant factor in the analysis of gene expression by quantitative RT-PCR is 
the election of a good control gene to ensure an adequate normalization of the 
results in the quantification of the expression. Although the scientific literature 
normally refers to housekeeping genes as synonyms of reference or control genes, 
these terms should not be indistinctly used, as many housekeeping genes vary 
greatly with different experimental or pathophysiological conditions. 
In fact, our work shows that genes commonly used in these types of studies vary 
significantly in both depots of adipose tissue in lean and obese individuals. 
The adipose tissue is not considered any more as a mere deposit of fat, but an 
organ with an essential endocrine role.  The molecular mechanisms causing the 
hyperplasia or hypertrophy of this tissue have not fully identified, thus studies on 
gene expression can help to better understand the processes leading to obesity. 
ACTB, GAPDH and 18S are the most commonly used genes to correct loading in 
gene expression studies (2, 22, 23). However, the present study shows they are the 
least stable genes studied, considering both depots, from the 16 ones used in the 
commercial microfluidic cards, as their CV were above the 5% level. Although there 
are controversial results regarding the 18S in adipose tissue (8, 24) a drawback to 
its use as a control gene is the considerable imbalance between mRNA and rRNA 
fractions (25) with different polymerases involved in their transcription (26). 
Ribosomal expression is altered in some experimental conditions (27) and under 
certain biological factors and drugs (28, 29). In addition, 18S shows resistance to 
degradation as compared to mRNAs (21). As 18S has no introns, an additional error 
appears if DNAse treatment of the samples fails or is incomplete. 
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ACTB and GAPDH have been used extensively as single control genes (2). In 
adipose tissue ACTB is regulated by hypocaloric diets (30) while GAPDH is very 
sensitive to any perturbation in cellular homeostasis and experimental manipulation 
(2, 31, 32), as our results demonstrate in differentiation experiments. 
RT-PCR, geNORM and Normfinder programs were used to find the most suitable 
gene of a panel of 16 human genes that are commonly used as endogenous 
controls both in OM and SC adipose tissues. The most suitable gene was IPO8, 
which resulted the best choice using the 3 methods. At present, there are some 
statistical methods like geNORM, NormFinder, or Global Pattern Recognition for the 
optimization of reference gene selection. These methods have been compared with 
similar results in some reports (13, 33) but not in others (15).  
 
In this study, we also used our unpublished microarrays data to identify genes with 
low variation in expression levels in human adipose tissue. FBXL10 was the gene 
with the highest expression stability in OM and SC human adipose tissue. This gene 
codes for a nucleolar protein that represses transcription of ribosomal RNA genes 
(37). In addition to its low variation, FBXL10 has the characteristics of a 
housekeeping gene as it is an evolutionarily conserved and ubiquitously expressed  
member of the JHDM and it is essential for the maintenance of cellular function. 
When FBXL10 and IPO8 in adipose tissue were compared, both genes had a low 
CV, but IPO8 exhibited a better outcome.  
The choice of IPO8 as reference gene in human OM and SC adipose samples was 
further supported when 18S, FBXL10 and IPO8 were used to normalize common 
adipocytic genes such as leptin, interleukin 6 and adiponectin. IPO8 belongs to the 
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importins beta family, nuclear proteins involved in the nucleolar transport. Very 
recently it has been published that IPO8 is required for cytoplasmic miRNA-guided 
gene silencing and is involved in loading Ago complexes into a variety of different 
mRNA targets, affecting the nuclear localization of Ago proteins (34). IPO8 has 
been proposed previously as a reference gene in the human motor cortex as it 
showed no differences in a study with different brain regions from chronic alcoholics 
and control subjects (35) and lung samples (36).  
Both IPO8 and FBXL10 performed well when OM and SC primary differentiated 
preadipocytes were used under different treatments which can mimic some of the 
changes in the humans under distinct physiological and pharmacological status. 
Thus, in primary cultures of human OM adipocytes the CV of IPO8 was even better 
than in OM adipose tissue. Interestingly, FBXL10 showed a slightly better CV than 
IPO8 in omental differentiated preadipocytes in culture, but not in subcutaneous 
ones. It is noteworthy that neither IPO8 nor FBXL10 changed during the 
differentiation process reinforcing their role as control genes in these cells. 
Considering that the use of reference genes for gene expression studies is an 
important topic, and the fact that tissue/protocols or even types of subjects can differ 
among laboratories, we suggest that this kind of experiments should be performed 
with more than one reference gene. 
 In conclusion, based on the evidence provided in the present study, we propose 
and recommend IPO8 and FBXL10 as appropriate reference genes, which have not 
been previously identified for this purpose, in expression studies of human adipose 
tissue and cultured preadipocytes.    
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FIGURES LEGENDS 
Figure 1. Reference gene stability measurements. The GENORM and 
NORMFINDER softwares were used to calculate the most stable genes among the 
16 genes included in the Taqman low density human endogenous control panel. 
RNA samples of omental and subcutaneous adipose tissue from lean and obese 
patients were used.  The most stable genes are those with the lower values of 
stability. 
 
Figure 2. Effects of normalization by 3 reference genes (18S, IPO8 and FBXL10) on 
leptin (A, B), adiponectin (C, D) and interleukin 6 (E, F) mRNA expression in omental 
and subcutaneous adipose tissue of obese (n=33) and lean subjects (n=4). Data are 
mean ± SEM. * p< 0.05 
 
Figure 3. mRNA levels (expressed as mean Ct ± SEM) of FBXL10 (upper panel), 
IPO8 (middle panel) and GAPDH (lower panel) in omental and subcutaneous human 
preadipocytes at different days of differentiation (0, 6 and 12 days). *p< 0.05 vs its 
respective 0 day,  #p < 0.05 vs its respective 6 day. Data are from 3 independent 
experiments from each depot. 
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TABLE 1. Ranking of 16 commonly used housekeeping genes in OM and SC 
adipose tissue samples from obese and lean subjects, based on their CV%. 
   OM+SC SC OM 
SYMBOL   Mean Ct SD CV (%) Rank CV(%) Rank CV(%) Rank 
HPRT1 30.36 1.37 4.51 1 3.83 1 4.83 6 
IPO8 28.74 1.31 4.55 2 4.72 2 4.57 5 
HMBS 31.81 1.53 4.80 3 5.25 3 4.38 3 
TFRC 28.87 1.39 4.81 4 5.32 4 4.46 4 
POLR2A 27.97 1.37 4.90 5 6.13 7 3.71 1 
YWHAZ 31.18 1.58 5.07 6 6.09 6 4.24 2 
B2M 23.59 1.31 5.55 7 5.39 5 5.71 10 
PKG 26.17 1.54 5.88 8 6.34 9 5.66 9 
GUSB 29.07 1.72 5.91 9 6.56 10 5.56 8 
PPIA 24.85 1.48 5.95 10 6.70 11 5.45 7 
TBP 31.02 1.93 6.22 11 6.23 8 6.62 12 
UBC 24.71 1.72 6.94 12 8.07 14 5.74 11 
GADPH 26.10 1.84 7.06 13 7.59 13 6.90 13 
ACTB 23.72 1.93 8.12 14 8.68 15 7.96 14 
RPLP0 25.28 2.19 8.65 15 6.88 12 10.03 15 
18S 13.42 1.84 13.70 16 15.65 16 11.52 16 
 
OM, omental; SC, subcutaneous; CV, coefficient of variation; HPRT1, Hypoxanthine 
phosphoribosyl transferase 1; IPO8, importin 8; HMBS, Hidroxymethylbilane synthase; 
TFRC, Transferrin receptor; POLR2A, RNA Polymerase II; YWHAZ, Tyrosin 3-
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monooxygenase/tryptophan-monooxygenase activation protein; B2M, Beta-2-
microglobulin; PKG, Phosphoglycerate kinase; GUSB, beta-Glucuronidase; PPIA, 
Peptidylprolyl isomerase A; TBP, TATA binding protein; UBC, Ubiquitin C; GAPDH, 
Glyceraldehyde-3-phosphate dehydrogenase; ACTB, beta-Actin; RPLP0, Ribosomal 
large P0; 18S, 18S Ribosomal RNA. 
 
 
